Similarly, the absence of SIRT6 in mice enhanced glycolysis and triglyceride synthesis, with the consequent onset of nonalcoholic fatty liver disease (NAFLD) [55]. The gene discussed is SIRT6; the disease is metabolic dysfunction-associated steatotic liver disease.